11-47274631-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001376620.1(MADD):c.-74C>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,614,218 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0061 ( 13 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 12 hom. )
Consequence
MADD
NM_001376620.1 5_prime_UTR_premature_start_codon_gain
NM_001376620.1 5_prime_UTR_premature_start_codon_gain
Scores
1
17
Clinical Significance
Conservation
PhyloP100: 1.23
Genes affected
MADD (HGNC:6766): (MAP kinase activating death domain) Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.004262507).
BP6
Variant 11-47274631-C-A is Benign according to our data. Variant chr11-47274631-C-A is described in ClinVar as [Benign]. Clinvar id is 709997.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00608 (927/152342) while in subpopulation AFR AF= 0.0211 (875/41564). AF 95% confidence interval is 0.0199. There are 13 homozygotes in gnomad4. There are 437 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MADD | NM_001376620.1 | c.-74C>A | 5_prime_UTR_premature_start_codon_gain_variant | 2/33 | NP_001363549.1 | |||
MADD | NM_001376626.1 | c.-74C>A | 5_prime_UTR_premature_start_codon_gain_variant | 2/34 | NP_001363555.1 | |||
MADD | NM_001376627.1 | c.-74C>A | 5_prime_UTR_premature_start_codon_gain_variant | 2/36 | NP_001363556.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MADD | ENST00000706887.1 | c.131C>A | p.Thr44Asn | missense_variant | 3/37 | ENSP00000516604.1 |
Frequencies
GnomAD3 genomes AF: 0.00605 AC: 921AN: 152224Hom.: 13 Cov.: 33
GnomAD3 genomes
AF:
AC:
921
AN:
152224
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00147 AC: 369AN: 251440Hom.: 2 AF XY: 0.00106 AC XY: 144AN XY: 135906
GnomAD3 exomes
AF:
AC:
369
AN:
251440
Hom.:
AF XY:
AC XY:
144
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000564 AC: 825AN: 1461876Hom.: 12 Cov.: 32 AF XY: 0.000465 AC XY: 338AN XY: 727234
GnomAD4 exome
AF:
AC:
825
AN:
1461876
Hom.:
Cov.:
32
AF XY:
AC XY:
338
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00608 AC: 927AN: 152342Hom.: 13 Cov.: 33 AF XY: 0.00587 AC XY: 437AN XY: 74506
GnomAD4 genome
AF:
AC:
927
AN:
152342
Hom.:
Cov.:
33
AF XY:
AC XY:
437
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
100
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
220
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
MADD-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.;.;.;T;.;.;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;N;N;N;N;N;N;.;N;N;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0
.;.;B;B;B;B;B;.;.;B;B;.
Vest4
0.21, 0.24, 0.18, 0.20, 0.20, 0.20, 0.16, 0.23
MVP
MPC
0.40
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at